Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | PDE7A | Q13946 | 7/20 | 0.49 |
| ▸ | PDE7B | Q9NP56 | 4/20 | 0.49 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31090891 | 1.00 | MAPK1 (0.59) | MAPK1TSHRVCAM1PARP1ALDH1A1 | |
| SCHEMBL2766183 | 0.83 | MAPK1 (0.64) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL1524058 | 0.80 | MAPK1 (0.72) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL9641099 | 0.80 | MAPK1 (0.40) | MAPK1TSHRVCAM1PARP1ALDH1A1 | |
| SCHEMBL358730 | 0.78 | MAPK1 (0.69) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL6125034 | 0.78 | MAPK1 (0.63) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL29394047 | 0.78 | MAPK1 (0.69) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL1665978 | 0.78 | PARP1 (0.56) | MAPK1TSHRPARP1ALDH1A1LMNA | |
| SCHEMBL2149474 | 0.77 | MAPK1 (0.61) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 | |
| SCHEMBL306375 | 0.77 | ALDH1A1 (0.64) | MAPK1TSHRVCAM1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600725-B2 | Selective GRP94 inhibitors and uses thereof | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-04-14 | — | — | US | disclosed |
| EP-3749325-B1 | DREADD ACTUATORS | US HEALTH (US) | 2026-04-08 | — | — | EP | disclosed |
| US-11825744-B2 | Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| US-11739063-B2 | DREADD actuators | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20230123747-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-04-20 | — | — | US | disclosed |
| CN-114057757-B | Organic compound containing heterocyclic structure, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-115109070-A | Compound containing indolo-heterocyclic structure and application thereof | 烟台显华科技集团股份有限公司 | 2022-09-27 | — | — | CN | disclosed |
| US-11267816-B2 | Selective Grp94 inhibitors and uses thereof | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-03-08 | — | — | US | disclosed |
| EP-0854867-B1 | TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS | GLAXO WELLCOME SPA (IT) | 2002-07-31 | — | — | EP | disclosed |
| US-6037471-A | FOR ELECTROCHROMIC MIRRORS FOR MOTOR VEHICLES | GENTEX CORPORATION (US) | 2000-03-14 | — | — | US | disclosed |
| US-6020987-A | Electrochromic medium capable of producing a pre-selected color | GENTEX CORPORATION (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0972227-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 2000-01-19 | — | — | EP | disclosed |
| US-5998617-A | MIXTURE OF ELECTROACTIVE MATERIALS AT PRESELECTIVE CONCENTRATION; GRAY COLOR | GENTEX CORPORATION (US) | 1999-12-07 | — | — | US | disclosed |
| US-5977136-A | Tetrahydroquinolines as NMDA antagonists | GLAXO WELLCOME SPA (IT) | 1999-11-02 | — | — | US | disclosed |
| WO-1998044384-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 1998-10-08 | — | — | WO | disclosed |
| EP-0854867-A1 | TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS | GLAXO WELLCOME S.p.A. (IT) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997012870-A1 | TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS | GLAXO WELLCOME S.P.A. (IT) | 1997-04-10 | — | — | WO | disclosed |
| US-5106407-A | Algicides, funcilides, bactericides | THE DOW CHEMICAL COMPANY (US) | 1992-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739063-B2 | DREADD actuators | GRK1, GRK3, GRK2 | MAPK1 1244/4885TSHR 255/4885VCAM1 3370/4885 |
| US-11825744-B2 | Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device | PIEZO1, OCIAD1, AQP1 | MAPK1 431/4885TSHR 4666/4885VCAM1 678/4885 |
| US-11267816-B2 | Selective Grp94 inhibitors and uses thereof | HSP90B1, HSP90AB2P, HSPE1 | MAPK1 2532/4885TSHR 3467/4885VCAM1 2562/4885 |
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | OCIAD1, OCIAD2, EPCAM | MAPK1 3722/4885TSHR 4444/4885VCAM1 1724/4885 |
| US-12600725-B2 | Selective GRP94 inhibitors and uses thereof | GRPR, HSPB1, HSP90AB2P | MAPK1 2324/4885TSHR 454/4885VCAM1 4364/4885 |
| US-20230123747-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | HSP90B1, HSP90AB2P, HSPE1 | MAPK1 2532/4885TSHR 3467/4885VCAM1 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.